Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: An ACTTION study

[1]  W. Rief,et al.  The placebo response in medicine: minimize, maximize or personalize? , 2013, Nature Reviews Drug Discovery.

[2]  M. Rowbotham,et al.  Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations , 2012, PAIN.

[3]  W. Rief,et al.  Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials , 2011, Clinical pharmacology and therapeutics.

[4]  M. Tohen,et al.  Factors modifying drug and placebo responses in randomized trials for bipolar mania. , 2011, The international journal of neuropsychopharmacology.

[5]  P. Enck,et al.  The placebo response in clinical trials: more questions than answers , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[6]  R. Temple,et al.  Enrichment of Clinical Study Populations , 2010, Clinical pharmacology and therapeutics.

[7]  T. Wager,et al.  Separate mechanisms for placebo and opiate analgesia? , 2010, Pain.

[8]  B. Colagiuri.  Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity , 2010, Clinical trials.

[9]  T. Kaptchuk,et al.  Biological, clinical, and ethical advances of placebo effects , 2010, The Lancet.

[10]  C. Rand,et al.  Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. , 2009, The Journal of allergy and clinical immunology.

[11]  James P. Young,et al.  Progress in Neurotherapeutics and Neuropsychopharmacology: Randomized Clinical Trials of Pregabalin for Neuropathic Pain: Methods, Results, and Implications , 2008 .

[12]  Mark Zimmerman,et al.  Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials , 2007, British Journal of Psychiatry.

[13]  M. Versavel,et al.  Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trial , 2006, Current medical research and opinion.

[14]  David A. Williams,et al.  Characterization and consequences of pain variability in individuals with fibromyalgia. , 2005, Arthritis and rheumatism.

[15]  L. Lamoreaux,et al.  Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. , 2005, The journal of pain : official journal of the American Pain Society.

[16]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[17]  R. Poole,et al.  Pregabalin relieves symptoms of painful diabetic neuropathy , 2004, Neurology.

[18]  J. Rosenstock,et al.  Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.

[19]  M. Versavel,et al.  Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial , 2004, Pain.

[20]  R. Poole,et al.  Pregabalin for the treatment of postherpetic neuralgia , 2003, Neurology.

[21]  G. Keitner,et al.  A reevaluation of the exclusion criteria used in antidepressant efficacy trials. , 2002, The American journal of psychiatry.

[22]  J. Farrar,et al.  Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale , 2001, PAIN.

[23]  S. Fisher,et al.  Placebo washout is not a meaningful part of antidepressant drug trials. , 1995, Perceptual and motor skills.

[24]  J. Kleijnen,et al.  Placebo effect in double-blind clinical trials: a review of interactions with medications , 1994, The Lancet.

[25]  H. Fields,et al.  MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.

[26]  J. R Gibbs,et al.  TREATMENT OF EXCESSIVE AXILLARY SWEATING , 1974 .

[27]  R. Freeman,et al.  Efficacy, safety and tolerability of pregabalin treatment of painful diabetic peripheral neuropathy: findings from 7 randomized, controlled trials across a range of doses , 2008 .

[28]  Kathryn A Sexton,et al.  Does elimination of placebo responders in a placebo run‐in increase the treatment effect in randomized clinical trials? A meta‐analytic evaluation , 2004, Depression and anxiety.